<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">Ribavirin is abroad spectrum antiviral agent acting by induction of mutations in the viral genome, especially in RNA viruses [
 <xref rid="bb0120" ref-type="bibr">24</xref>]. Ribavirin is officially approved for treating respiratory syncytial virus (RSV) infection and, in combination with interferon Î±2b for hepatitis C virus [
 <xref rid="bb0125" ref-type="bibr">25</xref>]. In addition, it was used for treating SARS CoV infections [
 <xref rid="bb0125" ref-type="bibr">25</xref>]. Given the high similarity of SARS and COVID-19 Mpros, ribavirin might be of a value in treating COVID-19.
</p>
